Enzo Biochem (NYSE:ENZ) Earns Hold Rating from Analysts at StockNews.com

StockNews.com initiated coverage on shares of Enzo Biochem (NYSE:ENZ) in a research report released on Wednesday morning. The brokerage issued a hold rating on the medical research company’s stock.

Enzo Biochem Price Performance

Shares of Enzo Biochem stock opened at $1.13 on Wednesday. The business has a 50 day simple moving average of $1.13 and a two-hundred day simple moving average of $1.12. Enzo Biochem has a 12 month low of $0.99 and a 12 month high of $1.50.

Enzo Biochem Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, December 2nd. Shareholders of record on Friday, November 15th will be issued a $0.10 dividend. The ex-dividend date of this dividend is Friday, November 15th. This represents a $0.40 dividend on an annualized basis and a yield of 35.40%.

Institutional Investors Weigh In On Enzo Biochem

A hedge fund recently raised its stake in Enzo Biochem stock. XTX Topco Ltd grew its holdings in Enzo Biochem, Inc. (NYSE:ENZ) by 94.5% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 28,262 shares of the medical research company’s stock after purchasing an additional 13,735 shares during the quarter. XTX Topco Ltd owned about 0.05% of Enzo Biochem worth $31,000 as of its most recent SEC filing. 36.90% of the stock is currently owned by institutional investors and hedge funds.

About Enzo Biochem

Enzo Biochem, Inc develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis.